2364-1746

Pulmonary Therapy

Springer-Verlag

View prefix report (10.1007)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 320 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact320 DOIs
2

Attach ORCID iDs across 165 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact165 DOIs
3

Add license metadata to 32 records

License metadata tells indexers and readers how each article may be reused.

Low impact32 DOIs

DOIs for this ISSN

Showing the top 5 of 352 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A Review on the Safety and Efficacy of Inhaled Corticosteroi… (10.1007/s41030-017-0043-5)
Abstract ORCID License
138.38 69
2 Potential Benefit of Repeated Dry Powder Inhaler’s Inhalatio… (10.1007/s41030-015-0004-9)
Abstract ORCID License
123.99 44
3 Effect of Nebulizer Designs on Aerosol Delivery During Non-I… (10.1007/s41030-017-0033-7)
Abstract ORCID License
120.15 39
4 3D Printing and Personalized Airway Stents (10.1007/s41030-016-0026-y)
Abstract ORCID License
117.62 36
5 The Respimat® Development Story: Patient-Centered Innovation (10.1007/s41030-017-0040-8)
Abstract ORCID License
116.72 35
6 A Network Meta-Analysis of Long-Acting Muscarinic Antagonist… (10.1007/s41030-017-0048-0)
Abstract ORCID License
114.86 33
7 Improving the Efficiency of Respiratory Drug Delivery: A Rev… (10.1007/s41030-017-0046-2)
Abstract ORCID License
109.68 28
8 Budesonide/Formoterol Easyhaler®: Performance Under Simulate… (10.1007/s41030-016-0025-z)
Abstract ORCID License
95.91 18
9 Colobreathe® for the Treatment of Cystic Fibrosis-Associated… (10.1007/s41030-015-0007-6)
Abstract ORCID License
92.28 16
10 Identification of Asthma Subtypes Using Clustering Methodolo… (10.1007/s41030-016-0017-z)
Abstract ORCID
90.98 65
11 Validation of a New Portable Exhaled Nitric Oxide Analyzer,… (10.1007/s41030-017-0032-8)
Abstract ORCID License
90.31 15
12 Safety of Pirfenidone in Patients with Idiopathic Pulmonary… (10.1007/s41030-017-0049-z)
Abstract ORCID License
90.31 15
13 In-Vitro Characterization of the Aerosolized Dose During Non… (10.1007/s41030-015-0010-y)
Abstract ORCID
89.62 61
14 A Real-World Study of 30-Day Exacerbation Outcomes in Chroni… (10.1007/s41030-017-0027-5)
Abstract ORCID License
88.21 14
15 Impact of Inhalation Flow, Inhalation Volume and Critical Ha… (10.1007/s41030-017-0042-6)
Abstract ORCID License
88.21 14
16 Ex Vivo Lung Perfusion: A Review of Current and Future Appli… (10.1007/s41030-022-00185-w)
Abstract ORCID
84.06 47
17 Treatment of Persistent Cough in Subjects with Idiopathic Pu… (10.1007/s41030-021-00162-9)
Abstract ORCID
82.17 43
18 Obstructive Sleep Apnea: A Syndrome from Childhood to Old-Ag… (10.1007/s41030-015-0005-8)
Abstract ORCID License
80.94 11
19 Collaborative Care: A Defining Characteristic for a Pulmonar… (10.1007/s41030-017-0039-1)
Abstract ORCID License
80.94 11
20 Chronic Cough in Adults: Make the Diagnosis and Make a Diffe… (10.1007/s41030-019-0089-7)
Abstract ORCID
78.99 37
21 A 2019 Update on Occupational Lung Diseases: A Narrative Rev… (10.1007/s41030-020-00143-4)
Abstract ORCID
78.41 36
22 Aerosol Deposition of Inhaled Corticosteroids/Long-Acting β2… (10.1007/s41030-017-0036-4)
Abstract License
76.57 33
23 Critically Ill Patients with COVID-19: A Narrative Review on… (10.1007/s41030-020-00135-4)
Abstract ORCID
76.57 33
24 In Vitro Study of the Effect of Breathing Pattern on Aerosol… (10.1007/s41030-019-0086-x)
Abstract ORCID
73.12 28
25 Extracorporeal Membrane Oxygenation in Acute Respiratory Fai… (10.1007/s41030-023-00214-2)
Abstract ORCID
69.01 23
26 Effects of Hormone Replacement Therapy on Women's Lung Healt… (10.1007/s41030-023-00240-0)
Abstract ORCID
67.12 21
27 The Impact of Malnutrition on the Developing Lung and Long-T… (10.1007/s41030-024-00257-z)
Abstract ORCID
67.12 21
28 A Phase 1b Study of Vismodegib with Pirfenidone in Patients… (10.1007/s41030-019-0096-8)
Abstract ORCID
63.94 18
29 Switching Inhalers: A Practical Approach to Keep on UR RADAR (10.1007/s41030-020-00133-6)
Abstract ORCID
63.94 18
30 Impact of PIF, Inhalation Technique and Medication Adherence… (10.1007/s41030-021-00172-7)
Abstract ORCID
63.94 18
31 Repository Corticotropin Injection for the Treatment of Pulm… (10.1007/s41030-022-00181-0)
Abstract ORCID
63.94 18
32 Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Lon… (10.1007/s41030-016-0012-4)
Abstract ORCID
58.80 14
33 Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Main… (10.1007/s41030-018-0057-7)
Abstract ORCID
58.80 14
34 Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Hea… (10.1007/s41030-019-0087-9)
Abstract ORCID
58.80 14
35 Air Pollution and Asthma: Critical Targets for Effective Act… (10.1007/s41030-020-00138-1)
Abstract ORCID
58.80 14
36 The Impact of Risk Factors on Treatment Outcomes of Nosocomi… (10.1007/s41030-021-00175-4)
Abstract ORCID
57.31 13
37 Real-World Long-Term Ivacaftor for Cystic Fibrosis in France… (10.1007/s41030-021-00158-5)
Abstract ORCID
55.70 12
38 Aerosol Delivery to a Critically Ill Patient: A Big Issue Ea… (10.1007/s41030-018-0060-z)
Abstract ORCID
53.96 11
39 A Real-Life One-Year Non-Interventional Study Assessing Safe… (10.1007/s41030-021-00150-z)
Abstract ORCID
53.96 11
40 Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Su… (10.1007/s41030-025-00303-4)
Abstract ORCID
53.96 11
41 Successful Fractional Exhaled Nitric Oxide Measurements with… (10.1007/s41030-017-0028-4)
Abstract ORCID License
52.42 4
42 Idiopathic Pulmonary Arterial Hypertension in Children: A Re… (10.1007/s41030-017-0035-5)
Abstract ORCID License
52.42 4
43 A Retrospective Study of the Effectiveness of the AeroChambe… (10.1007/s41030-017-0047-1)
Abstract ORCID License
52.42 4
44 Effectiveness and Patient Satisfaction with Budesonide/Formo… (10.1007/s41030-019-0097-7)
Abstract ORCID
52.07 10
45 Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative… (10.1007/s41030-021-00174-5)
Abstract ORCID
52.07 10
46 Safety of Macitentan for the Treatment of Portopulmonary Hyp… (10.1007/s41030-023-00251-x)
Abstract ORCID
50.00 9
47 In Vitro Effect of Different Airflow Rates on the Aerosol Pr… (10.1007/s41030-020-00125-6)
Abstract ORCID
47.71 8
48 Use of a Digital Chronic Obstructive Pulmonary Disease Respi… (10.1007/s41030-021-00168-3)
Abstract ORCID
47.71 8
49 Gaps and Future Directions in Clinical Research on Obesity-R… (10.1007/s41030-023-00230-2)
Abstract ORCID
47.71 8
50 A Clinical Study to Assess the Efficacy and Safety of MP-Aze… (10.1007/s41030-023-00238-8)
Abstract ORCID
47.71 8